- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04939025
Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC (MIRACLE)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Ulcerative colitis is an inflammatory bowel disorder that affects predominantly young patients interfering with their social, family and professional life's (Ungaro, Mehandru, Allen, Peyrin-Biroulet, & Colombel, 2017). When the disease is moderate to severe, it is difficult to control medically even in the era of the biologic treatment. Colectomy rates are reported to be as high as 50% after 5 years in patients admitted with a severe exacerbation (Duijvis et al., 2016; Thorne et al., 2016). In a modified two (colectomy first followed by completion proctectomy and pouch) or three stage procedure (colectomy first followed by completion proctectomy and pouch with diverting ileostomy, finally stoma closure) a proctocolectomy is done and continuity can be restored with a ileoanal pouch (Sahami, Buskens, et al., 2016; Zittan et al., 2016). These are the preferred options for the majority of our patients. Alternatives are proctocolectomy with definitive end-ileostomy or a continent ileostomy.
Quality of life of patients with pouches depends predominantly on proper function of the pouch. Inadequate function and long term pouch failure are determined by the occurrence of chronic anastomotic leaks, chronic pouchitis and a delayed diagnosis of Crohn's disease in and around the pouch (Lightner et al., 2017). The latter two diagnoses, Crohn's disease and chronic pouchitis are in an important number in fact misdiagnosed chronic leaks (Garrett et al., 2009; van der Ploeg, Maeda, Faiz, Hart, & Clark, 2017). Long-term pouch failure rates (pouch excision or secondary diversion of the pouch) add up to more than 1 out of 10 at 10 years (Ikeuchi et al., 2018; Lightner et al., 2017; Mark-Christensen et al., 2018). These data represent the results of expert centers, so real life data are probably worse. Chronic leaks are late sequalae leaking anastomosis which has been inadequately treated; misdiagnosed or diagnosed too late to treat successfully.
Although many centers publish more favorable figures, the true rate of anastomotic leakage of ileoanal pouches probably varies from 10-20% (Sahami, Bartels, et al., 2016; Sossenheimer et al., 2019; Widmar et al., 2019). There is an important underreporting of the leaks. If the pouch is diverted, the leak will only become apparent prior to ileostomy closure when the anastomosis is tested. Even testing the anastomosis is not 100% accurate accounting for a number of misdiagnosed leaks. These misdiagnosed and delayed diagnosed leaks are generally not included in series reporting short term results (Santorelli, Hollingshead, & Clark, 2018; Sossenheimer et al., 2019; Widmar et al., 2019).
For all these reasons it is of great importance to prevent anastomotic leakage when creating a ileoanal pouch and if it happens, to solve the problem as soon as possible.
Numerous risk factors have been identified for anastomotic leakage. The most important factors are tension on the anastomosis, inadequate vascularization of the pouch, an unfavorable microbiome and the use of immunosuppressive drugs (steroids, immunomodulators, biologic treatments). By staging the restorative proctocolectomy, the negative impact of immunosuppressive drugs on anastomotic healing are avoided because at the time of the pouch creation the drugs are weaned for a long period. Other factors including anastomotic technique and anastomotic perfusion are modifiable surgical factors. A more recently described pathophysiological mechanism relates to the intestinal microbiome (Alverdy, Hyoju, Weigerinck, & Gilbert, 2017). Apparently, this holds true for small bowel surgery as well (Lesalnieks, Hoene, Bittermann, Schlitt, & Hackl, 2018).
Proper management of a leak comprises early diagnosis and immediate and adequate management. Sequential CRP measurement and early investigation of the integrity of the anastomosis are key for early diagnosis, particularly in a diverted anastomosis which might not be symptomatic (Adamina et al., 2015; Warschkow et al., 2012).
The current management of the leak usually involves a diverting ileostomy, if not performed primarily, in combination with passive drainage of the abscess cavity via transanal or transcutaneous route. This approach showed to be relatively ineffective leading to a pouch failure rate of 20%, and if resolved to a worse pouch function (Garrett et al., 2009; Lightner et al., 2017).
Endosponge vacuum assisted closure (EVAC) of the anastomotic leak on the contrary showed to have a very high success rate and to prevent long-term pouch dysfunction and failure (Bemelman & Baron, 2018; Gardenbroek et al., 2015; Verlaan et al., 2011; Weidenhagen, Gruetzner, Wiecken, Spelsberg, & Jauch, 2008).
There is minimal risk to patients as there is no introduction of a novel technique, rather this study is an amalgamation of published improvements in pouch surgery pre, intra and post-operatively to reduce the leak rate at one year.
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Mohammed Deputy
- Telefonnummer: +447958395012
- E-post: m.deputy@nhs.net
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Diagnosis of Ulcerative Colitis
- Diagnosis of Crohn's disease limited to the colon without any history of perianal disease
- Modified two or three stage restorative proctocolectomy
- Age above 18
- Able to fill in questionnaires in local language and to come to out-patient-clinic visits;
Exclusion Criteria:
- Known allergy to ICG, or iodide allergy.
- Pregnancy
- Redo pouch operation
- Age under 18
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Sekventiell tilldelning
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Inget ingripande: Historic cohort
|
|
Övrig: Multi-interventional program cohort
|
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Leak rate
Tidsram: 1 year
|
Anastomotic integrity at one year postoperatively defined as the absence of presacral collections, anastomotic fistula and severe anastomotic stricture (not amenable for digital dilatation by rectal exam).
|
1 year
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Död
Tidsram: 1 år
|
Död
|
1 år
|
Cumulative anastomotic dehiscence rate
Tidsram: 18 month
|
Anastomotic insufficiency at 30 days, 6 months and 12 months defined as contrast extravasation and/or presacral perianastomotic fluid collections on CT scan or Anastomotic dehiscence at endoscopy.
|
18 month
|
QOL
Tidsram: 3,6,12 and 18 months
|
Quality of life and functional outcomes preoperatively and then 3, 6, 12 and 18 months post-operatively.
|
3,6,12 and 18 months
|
Protocol compliance
Tidsram: 18 month
|
Protocol compliance to any intervention
|
18 month
|
ICG
Tidsram: Operative
|
Change in management due to ICG
|
Operative
|
CRP
Tidsram: 30 days
|
Diagnostic accuracy of CRP for anastomotic leakage
|
30 days
|
EVAC
Tidsram: 18 month
|
Efficacy of EVAC with early transanal closure of the anastomotic defect
|
18 month
|
Stoma rate
Tidsram: 18 month
|
Permanent stoma rate at 18 months
|
18 month
|
Temporary ileostomy rate and duration
Tidsram: 18 month
|
Temporary stoma rate and stoma duration at 18 months
|
18 month
|
Complications
Tidsram: 1 year
|
Operative and post-operative complications within 30 days and 12 months (cumulative) of operation (using the Clavien-Dindo classification of surgical complications)
|
1 year
|
Hospital stay
Tidsram: 1 year
|
Hospital stay and total hospital stay at one year
|
1 year
|
Reintervention rate
Tidsram: 18 month
|
Reintervention rate
|
18 month
|
Readmission
Tidsram: 18 month
|
Overall and stoma-related readmission
|
18 month
|
Cost analysis of EVAC
Tidsram: 18 month
|
Cost analysis of anastomotic leakage and EVAC therapy
|
18 month
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Förväntat)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 271078
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Ulcerös kolit
-
Michael E Villarreal, MDMerck Sharp & Dohme LLCAvslutadClostridia Difficile Colitis | Clostridium; SepsisFörenta staterna
-
Groupe d'Etude Therapeutique des Affections Inflammatoires...AvslutadULCERATIV KOLITFrankrike, Belgien
-
Nantes University HospitalInstitut National de la Santé Et de la Recherche Médicale, France; Takeda; Mauna Kea TechnologiesAvslutad
-
Jewish General HospitalAvslutadFulminant Clostridium Difficile ColitisKanada
-
University of AlbertaUniversity of British Columbia; McGill University; University of CalgaryAktiv, inte rekryterandeClostridium Difficile Diarré | Clostridia Difficile ColitisKanada
-
University of VirginiaImperial College LondonRekryteringClostridium Difficile-infektion | Clostridium Difficile Diarré | Clostridioides Difficile-infektion | Clostridia Difficile ColitisFörenta staterna
Kliniska prövningar på Multi-interventional program
-
Milton S. Hershey Medical CenterAvslutadAspergers sjukdom | Högfungerande autismFörenta staterna
-
University Hospital, BonnAvslutad
-
AstraZenecaAvslutadBröstcancer | Onkologi | EpidemiologiAlgeriet
-
National University of SingaporeRekryteringMajor depressiv sjukdomSingapore
-
Sorlandet Hospital HFUniversity Hospital of North Norway; Haukeland University Hospital; St. Olavs...RekryteringCerebral pares | Hjärnskador | Förälder-barn relationer | Föräldraskap | Motoriska störningar | BemyndigandeNorge
-
AlvimedicaAvslutadKärlsjukdomar | Kranskärlssjukdom | KranskärlssjukdomKalkon
-
Penn State UniversityThe University of Texas Health Science Center at San Antonio; University... och andra samarbetspartnersRekryteringPosttraumatisk stressyndromFörenta staterna
-
GGZ CentraalUMC Utrecht; Maastricht University; Stichting tot steun VCVGZ; The Healthcare...RekryteringMental sjukdom | LivsstilNederländerna
-
Fundación Eduardo AnituaRekrytering
-
KA Imaging Inc.Grand River HospitalOkändSolitär lungknöl | LungtumörKanada